Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-17-008691
Filing Date
2017-02-14
Accepted
2017-02-14 15:24:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v459204_sc13ga.htm SC 13G/A 53060
  Complete submission text file 0001144204-17-008691.txt   54568
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 17607853
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 WEST ADAMS STREET CHICAGO IL 60606
Business Address 222 WEST ADAMS STREET CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

EIN.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A